Found: 20
Select item for more details and to access through your institution.
Optical coherence tomography angiography detects retinal vascular alterations in different phases of multiple sclerosis.
- Published in:
- 2019
- By:
- Publication type:
- Letter to the Editor
Corrigendum.
- Published in:
- 2019
- Publication type:
- Correction Notice
Commentary on Al Hussona et al. 'New-onset seizures as a sole clinical presentation of multiple sclerosis'.
- Published in:
- Multiple Sclerosis Journal, 2019, v. 25, n. 2, p. 298, doi. 10.1177/1352458518781978
- By:
- Publication type:
- Article
New onset seizures as a sole clinical presentation of multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2019, v. 25, n. 2, p. 295, doi. 10.1177/1352458518781994
- By:
- Publication type:
- Article
Test-retest agreement and reliability of the Six Spot Step Test in persons with multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2019, v. 25, n. 2, p. 286, doi. 10.1177/1352458517745725
- By:
- Publication type:
- Article
A multicenter randomized controlled trial of two group education programs for fatigue in multiple sclerosis: Short- and medium-term benefits.
- Published in:
- Multiple Sclerosis Journal, 2019, v. 25, n. 2, p. 275, doi. 10.1177/1352458517745723
- By:
- Publication type:
- Article
Change of olfactory function as a marker of inflammatory activity and disability progression in MS.
- Published in:
- Multiple Sclerosis Journal, 2019, v. 25, n. 2, p. 267, doi. 10.1177/1352458517745724
- By:
- Publication type:
- Article
Neural correlates of effort-dependent and effort-independent cognitive fatigue components in patients with multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2019, v. 25, n. 2, p. 256, doi. 10.1177/1352458517743090
- By:
- Publication type:
- Article
Amiloride does not protect retinal nerve fibre layer thickness in optic neuritis in a phase 2 randomised controlled trial.
- Published in:
- Multiple Sclerosis Journal, 2019, v. 25, n. 2, p. 246, doi. 10.1177/1352458517742979
- By:
- Publication type:
- Article
Safety and tolerability of inebilizumab (MEDI-551), an anti-CD19 monoclonal antibody, in patients with relapsing forms of multiple sclerosis: Results from a phase 1 randomised, placebo-controlled, escalating intravenous and subcutaneous dose study.
- Published in:
- Multiple Sclerosis Journal, 2019, v. 25, n. 2, p. 235, doi. 10.1177/1352458517740641
- By:
- Publication type:
- Article
Optical coherence tomography angiography indicates associations of the retinal vascular network and disease activity in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2019, v. 25, n. 2, p. 224, doi. 10.1177/1352458517750009
- By:
- Publication type:
- Article
Validating the use of brain volume cutoffs to identify clinically relevant atrophy in RRMS.
- Published in:
- Multiple Sclerosis Journal, 2019, v. 25, n. 2, p. 217, doi. 10.1177/1352458517743804
- By:
- Publication type:
- Article
Smoking and its interaction with genetics in MS etiology.
- Published in:
- Multiple Sclerosis Journal, 2019, v. 25, n. 2, p. 180, doi. 10.1177/1352458518801727
- By:
- Publication type:
- Article
Imaging patterns of gray and white matter abnormalities associated with PASAT and SDMT performance in relapsing-remitting multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2019, v. 25, n. 2, p. 204, doi. 10.1177/1352458517743091
- By:
- Publication type:
- Article
Insights into microbiome research 5: Mapping is first but function must come next.
- Published in:
- Multiple Sclerosis Journal, 2019, v. 25, n. 2, p. 193, doi. 10.1177/1352458518811203
- By:
- Publication type:
- Article
We need to conduct clinical trials of disease-modifying therapy in pregnancy to optimize care of women with MS - Commentary.
- Published in:
- Multiple Sclerosis Journal, 2019, v. 25, n. 2, p. 190, doi. 10.1177/1352458518808205
- By:
- Publication type:
- Article
We need to conduct clinical trials of disease-modifying therapy in pregnancy to optimize care of women with MS - No.
- Published in:
- Multiple Sclerosis Journal, 2019, v. 25, n. 2, p. 189, doi. 10.1177/1352458518795398
- By:
- Publication type:
- Article
We need to conduct clinical trials of disease-modifying therapy in pregnancy to optimize care of women with MS - Yes.
- Published in:
- Multiple Sclerosis Journal, 2019, v. 25, n. 2, p. 187, doi. 10.1177/1352458518794061
- By:
- Publication type:
- Article
Peripapillary retinal nerve fibre layer as measured by optical coherence tomography is a prognostic biomarker not only for physical but also for cognitive disability progression in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2019, v. 25, n. 2, p. 196, doi. 10.1177/1352458517740216
- By:
- Publication type:
- Article
Corrigendum.
- Published in:
- 2019
- Publication type:
- Correction Notice